Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $466B
1-Year Est. Return 20.66%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Quarter Est. Return
1 Year Est. Return
+20.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$466B
AUM Growth
+$34.1B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,356
New
Increased
Reduced
Closed

Top Buys

1 +$520M
2 +$440M
3 +$293M
4
AVGO icon
Broadcom
AVGO
+$268M
5
MSFT icon
Microsoft
MSFT
+$256M

Top Sells

1 +$453M
2 +$237M
3 +$217M
4
SKX
Skechers
SKX
+$201M
5
COF icon
Capital One
COF
+$187M

Sector Composition

1 Technology 21.99%
2 Financials 17.98%
3 Industrials 11.99%
4 Consumer Discretionary 10.49%
5 Healthcare 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUNG icon
2976
Pulmonx
LUNG
$102M
$558K ﹤0.01%
344,467
-110,877
TYRA icon
2977
Tyra Biosciences
TYRA
$1.23B
$555K ﹤0.01%
39,679
-2,002
TSQ icon
2978
Townsquare Media
TSQ
$88.2M
$555K ﹤0.01%
82,599
+8,691
KALV icon
2979
KalVista Pharmaceuticals
KALV
$804M
$554K ﹤0.01%
45,444
-127,765
EXFY icon
2980
Expensify
EXFY
$145M
$552K ﹤0.01%
297,856
-83,090
SLNO icon
2981
Soleno Therapeutics
SLNO
$2.66B
$548K ﹤0.01%
+8,102
BAM icon
2982
Brookfield Asset Management
BAM
$85.6B
$547K ﹤0.01%
9,606
-264
CHCI icon
2983
Comstock Holding Companies
CHCI
$128M
$543K ﹤0.01%
38,775
+2,704
PCH icon
2984
PotlatchDeltic
PCH
$3.12B
$540K ﹤0.01%
+13,259
NTWK icon
2985
NetSol Technologies
NTWK
$36.1M
$532K ﹤0.01%
111,976
+2,729
JFIN
2986
Jiayin Group
JFIN
$350M
$520K ﹤0.01%
+50,413
MIRM icon
2987
Mirum Pharmaceuticals
MIRM
$3.47B
$514K ﹤0.01%
+7,018
ACIU icon
2988
AC Immune
ACIU
$331M
$513K ﹤0.01%
177,111
-21,575
MIND icon
2989
MIND Technology
MIND
$71.8M
$513K ﹤0.01%
63,423
-106
BNED icon
2990
Barnes & Noble Education
BNED
$295M
$511K ﹤0.01%
51,365
+4,770
BOTJ icon
2991
Bank Of The James
BOTJ
$84.2M
$510K ﹤0.01%
32,665
BHM icon
2992
Bluerock Homes Trust
BHM
$36.4M
$508K ﹤0.01%
42,425
-375
CDLX icon
2993
Cardlytics
CDLX
$57.3M
$507K ﹤0.01%
208,430
-100,821
THRD
2994
DELISTED
Third Harmonic Bio
THRD
$505K ﹤0.01%
93,939
HNNA icon
2995
Hennessy Advisors
HNNA
$74.2M
$504K ﹤0.01%
47,828
-14,900
FDMT icon
2996
4D Molecular Therapeutics
FDMT
$658M
$504K ﹤0.01%
58,006
+2,069
SEER icon
2997
Seer Inc
SEER
$103M
$498K ﹤0.01%
229,181
-2,271
LIVE icon
2998
Live Ventures
LIVE
$45.3M
$494K ﹤0.01%
26,910
-5,126
CODA icon
2999
Coda Octopus Group
CODA
$104M
$494K ﹤0.01%
61,561
+1,562
SKIL icon
3000
Skillsoft
SKIL
$57.9M
$494K ﹤0.01%
37,938
-628